Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Soliris 300 mg concentrate for solution for infusion

Active Ingredient:
eculizumab
Company:  
Alexion Pharma UK Ltd See contact details
ATC code: 
L04AJ01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) User Manual Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Soliris Guide for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals

The aim of this guide is to help mitigate the risk of meningococcal infection associated with the use of SOLIRIS and to increase awareness of the need for the required vaccinations.

{pdf_link}

Soliris Guide for Patients/Parents/Caregivers

{healthcare_pro_orange} For Healthcare Professionals

This guide is intended to explain important safety information of eculizumab to patients and parents/caregivers of infants and children who are prescribed eculizumab.

{pdf_link}

Soliris Patient Card

{healthcare_pro_orange} For Healthcare Professionals

Important Safety Information for Patients Receiving Soliris®. Show this card to any doctor involved in your care.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Alexion Pharma UK Ltd
Company image
Address
2 Pancras Square, London, N1C 4AG, UK
Telephone
+44 (0) 208 744 6600
Fax
+44 (0) 20 8744 6630
Medical Information Direct Line
0800 028 4394
Customer Care direct line
0800 1300 212
Medical Information e-mail
[email protected]